‹ back to list

ViroGates A/S

E-health
Service&Operational
Rehab
Healthcare Buildings
Medical Devices
Pharmaceuticals

What we offer

Our health solution focusses on how the test for the suPAR biomarker can best be applied to help clinicians in their daily work. We offer different test technologies to suit different users and we collaborate with researchers to bring out more knowledge on various clinical aspects where suPAR might be of help.

Products and solutions

suPARnostic® is developed to measure the amount of suPAR protein in human blood. If individual's suPARnostic® level is very high, there is an increased risk of a negative outcome (e.g. mortality). Appropriate treatment should result in a lowered suPARnostic® level. suPARnostic® can improve the way seemingly low risk patients are managed - a low suPAR level helps avoid time and resources spent on further investigations, an elevated suPAR level is an indication that the patient is at higher risk of not surviving and it should be further investigated if this is caused by one or more developing diseases. By measuring an individual's suPARnostic® level, the patients risk of non-survival will be determined allowing the doctor to prioritise selection of treatment and monitoring.Link to product: Read More

Case stories

Link to three case stories:Read More

Contact


jk@virogates.com

ViroGates A/S

Blokken 45
3460 Birkerød

Find us here:

Others also viewed
A-Data A/S See profile ›
Rightimage2
建立商业合作-计划考察

我们可为您安排您在丹麦的 考察行程 。

了解更多
快讯 - 最新资讯
Newsletter
获取有关新闻,活动和公司资料的更新